Annexon, Inc. (ANNX)
4.535
-0.14
(-2.89%)
USD |
NASDAQ |
Sep 09, 10:30
Annexon Market Cap : 791.83M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 815.40M |
| September 04, 2026 | 850.32M |
| September 03, 2026 | 845.08M |
| September 02, 2026 | 860.80M |
| September 01, 2026 | 853.81M |
| August 31, 2026 | 862.54M |
| August 28, 2026 | 867.78M |
| August 27, 2026 | 916.67M |
| August 26, 2026 | 871.28M |
| August 25, 2026 | 899.21M |
| August 24, 2026 | 883.50M |
| August 21, 2026 | 885.24M |
| August 20, 2026 | 904.45M |
| August 19, 2026 | 960.32M |
| August 18, 2026 | 921.91M |
| August 17, 2026 | 895.72M |
| August 14, 2026 | 923.66M |
| August 13, 2026 | 918.42M |
| August 12, 2026 | 930.64M |
| August 11, 2026 | 932.39M |
| August 10, 2026 | 941.12M |
| August 07, 2026 | 879.13M |
| August 06, 2026 | 910.01M |
| August 05, 2026 | 872.63M |
| August 04, 2026 | 866.13M |
| Date | Value |
|---|---|
| August 03, 2026 | 853.13M |
| July 31, 2026 | 827.95M |
| July 30, 2026 | 856.38M |
| July 29, 2026 | 789.76M |
| July 28, 2026 | 807.63M |
| July 27, 2026 | 833.63M |
| July 24, 2026 | 848.26M |
| July 23, 2026 | 861.26M |
| July 22, 2026 | 849.88M |
| July 21, 2026 | 875.88M |
| July 20, 2026 | 905.13M |
| July 17, 2026 | 942.51M |
| July 16, 2026 | 957.14M |
| July 15, 2026 | 1.056B |
| July 14, 2026 | 901.88M |
| July 13, 2026 | 914.88M |
| July 10, 2026 | 942.51M |
| July 09, 2026 | 965.26M |
| July 08, 2026 | 968.51M |
| July 07, 2026 | 1.045B |
| July 06, 2026 | 968.51M |
| July 02, 2026 | 887.26M |
| July 01, 2026 | 901.88M |
| June 30, 2026 | 927.88M |
| June 29, 2026 | 905.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 21.34M |
| Krystal Biotech, Inc. | 10.25B |
| Immix Biopharma, Inc. | 919.95M |
| ACADIA Pharmaceuticals, Inc. | 4.782B |
| Alnylam Pharmaceuticals, Inc. | 34.02B |
Market Cap Related Metrics
| Price to Book Value | 4.256 |
| Price | 4.535 |
| Earnings Yield | -25.30% |